Filing metadata

Accession number
0001209191-22-032029
Form type
Form 3
Filer
Landos Biopharma, Inc.
CIK
CIK 1785345
Filed
May 26, 2022
Reporting period
May 16, 2022
Description
Initial ownership

Explore SEC Filings Hub